Description
DE-OBLIGATION - NEUROSURGERY
Base award description: IGF::OT::IGF NEUROSURGERY
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-04-01+$207,957= $207,957
- Mod P000012016-08-08+$0= $207,957
- Mod P000022016-10-01+$207,957= $415,913
- Mod P000062021-12-02-$121,887= $294,026
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-04-01 | +$207,957 | $207,957 | IGF::OT::IGF NEUROSURGERY |
| Mod P00001· CHANGE ORDER | 2016-08-08 | +$0 | $207,957 | IGF::OT::IGF NEUROSURGERY |
| Mod P00002· CHANGE ORDER | 2016-10-01 | +$207,957 | $415,913 | IGF::OT::IGF NEUROSURGERY |
| Mod P00006· FUNDING ONLY ACTION | 2021-12-02 | −$121,887 | $294,026 | DE-OBLIGATION - NEUROSURGERY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GY8NMUZQXVS7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926P0013 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $358,454 | FY2026 |
| 36C25926N0074 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $435,690 | FY2026 |
| 36C25925P0724 | NETWORK CONTRACT OFFICE 19 (36C259) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $35,984 | FY2025 |
| 36C24E25C0002 | RPO EAST (36C24E) · AJ14 · GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES | $39,502 | FY2025 |
| 36C25925N0026 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $429,877 | FY2025 |
| 36C26224P1817 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · R410 · SUPPORT- PROFESSIONAL: PROGRAM EVALUATION/REVIEW/DEVELOPMENT | $24,950 | FY2024 |
Other recipients under Q510 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626P0129 | NEUROMONITORING ASSOCIATES LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $24,000 | FY2026 |
| 36C25626N0185 | OZARK MEDICAL INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $452,818 | FY2026 |
| 36C25626N0024 | OZARK MEDICAL INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $355,702 | FY2026 |
| 36C25626N0005 | LOUISIANA STATE UNIVERSITY | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $285,553 | FY2026 |
| 36C25625D0032 | OZARK MEDICAL INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $1,317,900 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25616C0071_3600_-NONE-_-NONE- · retrieved 2026-09-26.